Effects of hormone replacement on growth hormone and prolactin exercise responses in postmenopausal women

Journal of Applied Physiology

Volumn 84, Issue 2, 1998, Pages 703-708

  Kraemer, R R ^a   Johnson, L G ^a   Haltom, R ^a   Kraemer, G R ^a   Gaines, H ^b   Drapcho, M ^b   Gimple, T ^c   Castracane, V Daniel ^c  

^a SOUTHEASTERN LOUISIANA UNIVERSITY   (United States)

^b North Oaks Medical Center   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Estrogen; Menopause; Somatotropin

Indexed keywords

ESTROGEN; GROWTH HORMONE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; ESTROGEN BLOOD LEVEL; EXERCISE; FEMALE; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROLACTIN RELEASE; TREADMILL;

EID: 0031892359     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.84.2.703     Document Type: Article

References (29)

1. Bellantoni, M. F., S. M. Harman, D. E. Cho, and M. R. Blackman. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J. Clin. Endocrinol. Metab. 72: 172-178, 1991.
2. Bellantoni, M. F., J. Vittone, A. T. Campfield, K. M. Bass, S. M. Harman, and M. R. Blackman. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J. Clin. Endocrinol. Metab. 81: 2848-2853, 1996.
3. Bunt, J. C., R. A. Boileau, J. W. Bahr, and R. A. Nelson. Sex and training differences in human growth hormone levels during prolonged exercise. J. Appl. Physiol. 61: 1796-1801, 1986.
4. Christiansen, C., M. S. Christiansen, P. McNair, C. Hagen, K. E. Stocklund, and S. B. Transbol. Prevention of early postmenopausal bone loss: controlled 2 year study in 315 normal females. Eur. J. Clin. Invest. 4: 273-279, 1980.
5. Dawson-Hughes, B., D. Stern, J. Goldman, and S. Reichlin. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J. Clin. Endocrinol. Metab. 63: 424-432, 1986.
6. DeMeirleir, K. L., L. Baeyens, M. L'Hermite-Baleriaux, M. L'Hermite, and W. Hollmann. Exercise-induced prolactin release is related to anaerobiosis. J. Clin. Endocrinol. Metab. 60: 1250-1252, 1985.
7. Dill, D. B., and D. L. Costill. Calculation of percentage changes in volumes of blood, plasma, and red cell dehydration. J. Appl. Physiol. 37: 247-248, 1974.
8. Friend, K. E., M. L. Hartman, S. S. Pezzoli, J. L. Clasey, and M. O. Thorner. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women. A clinical research center study. J. Clin. Endocrinol. Metab. 81: 2250-2256, 1996.
9. Grove, K. A., and B. R. Londeree. Bone density in postmenopausal women: high impact vs. low impact exercise. Med. Sci. Sports Exerc. 24: 1190-1194, 1992.
10. Ho, K. Y., W. S. Evans, R. M. Blizzard, J. D. Veldhuis, G. R. Merriam, E. Samojlik, R. Furlanetto, A. D. Rogol, D. L. Kaiser, and M. O. Thorner. Effects of sex, and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J. Clin. Endocrinol. Metab. 64: 51-57, 1987.
11. Howley, E. T., D. R. Bassett, and H. G. Welch. Criteria for maximal oxygen uptake: review and commentary. Med. Sci. Sports Exerc. 27: 1292-1301, 1995.
12. Isley, W. L., L. E. Underwood, and D. R. Clemmons. Dietary components that regulate serum somatomedin-C concentrations in humans. J. Clin. Invest. 71: 175-182, 1983.
13. Jackson, A. S., and J. H. Wilmore. Generalized equations for predicting body density of man. Br. Med. J. 40: 499-504, 1978.
14. Johannessen A., C. Hagen, and H. Galbo. Prolactin, growth hormone, thyrotropin, 3,5,3′-triiodothyronine, and thyroxine responses to exercise after fat- and carbohydrate-enriched diet. J. Clin. Endocrinol. Metab. 52: 56-61, 1981.
15. Johnson, L. G., R. R. Kraemer, R. Haltom, G. R. Kraemer, H. E. Gaines, and V. D. Castracane. Effect of estrogen replacement therapy on dehydrepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women. Fertil. Steril. 68: 836-843, 1997.
16. Keizer, H. A., H. Kuipers, J. de Haan, E. Beckers, and L. Habets. Multiple hormonal responses to physical exercise in eumenorrheic trained and untrained women. Int. J. Sports Med. 8: 139-150, 1987.
17. Kraemer, R. R., M. S. Blair, R. McCaferty, and V. D. Castracane. Running-induced alterations in growth hormone, prolactin, triiodothyronine, and thyroxine concentrations in trained and untrained men and women. Res. Q. Exerc. Sport 64: 69-74, 1993.
18. Kraemer, R. R., and B. S. Brown. Alterations in plasma-volume-corrected blood components of marathon runners and concomitant relationship to performance. Eur. J. Appl. Physiol. 55: 570-584, 1986.
19. Kraemer, R. R., R. J. Heleniak, J. L. Tryniecki, G. R. Kraemer, N. J. Okazaki, and V. D. Castracane. Follicular and luteal phase hormonal responses to low-volume resistive exercise. Med. Sci. Sports Exerc. 27: 809-817, 1995.
20. Kraemer, R. R., J. L. Kilgore, G. R. Kraemer, and V. D. Castracane. Growth hormone, IGF-I, and testosterone responses to resistive exercise. Med. Sci. Sports Exerc. 24: 1346-1352, 1992.
21. Kraemer, W. J., S. J. Fleck, J. E. Dziados, E. A. Harman, L. J. Marchitelli, S. E. Gordon, R. Mello, P. N. Frykman, L. P. Koziris, and N. T. Triplett. Changes in hormonal concentrations after different heavy-resistance exercise protocols in women. J. Appl. Physiol. 75: 594-604, 1993.
22. Loucks, A. B., and S. M. Horvath. Exercise-induced stress responses of amenorrheic and eumenorrheic runners. J. Clin. Endocrinol. Metab. 59: 1109-1120, 1984.
23. Nelson, M. E., C. N. Meredith, B. Dawson-Hughes, and W. J. Evans. Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J. Clin. Endocrinol. Metab. 66: 927-933, 1988.
24. Penalva, A., B. Burguera, X. Casabiell, J. Tresguerres, C. Dieguez, and F. Casanueva. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin? Neuroendocrinology 49: 551-554, 1989.
25. Raymond, V., M. Beaulieu, F. Labrie, and J. Boisssier. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200: 1173-1175, 1978.
26. Weissberger, A. J., K. Ho, and L. Lazarus. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J. Clin. Endocrinol. Metab. 72: 374-381, 1991.
27. Wilshire, G. B., J. S. Loughlin, J. R. Brown, T. E. Adel, and N. Santoro. Diminished function of the somatotropic axis in older reproductive-aged women. J. Clin. Endocrinol. Metab. 80: 608-613, 1995.
28. Wilson, J. D., and D. W. Foster (Editors). Williams Textbook of Endocrinology. Philadelphia, PA: Saunders, 1992, p. 226-228.
29. Xu, X., and W. E. Sonntag. Growth hormone and aging: regulation, signal transduction and replacement therapy. Trends Endocrinol. Metab. 7: 145-150, 1996.